z-logo
Premium
Neutron flux‐density and secondary‐particle energy spectra at the 184‐inch synchrocyclotron medical facility
Author(s) -
Smith A. R.,
Schimmerling W.,
Kanstein L. L.,
McCaslin J. G.,
Thomas R. H.
Publication year - 1981
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.595026
Subject(s) - neutron , beam (structure) , nuclear physics , physics , neutron flux , dosimetry , cyclotron , absorbed dose , spectral line , proton , atomic physics , flux (metallurgy) , charged particle , radiation , optics , nuclear medicine , materials science , electron , ion , astronomy , metallurgy , medicine , quantum mechanics
We have identified the sources of neutron production in the beam transport system of the 720‐MeV helium beam used for radiation therapy at the 184‐in synchrocyclotron of the Lawrence Berkeley Laboratory, and determined their magnitude. Measurements with activation detectors of differing energy response were used to unfold secondary particle spectra at various locations on the patient table. The effect of charged particles was estimated using a calculation of neutron‐flux densities derived from published cross sections. The absorbed dose, as a function of distance from the beam axis, was calculated using the unfolded spectra and evaluated fluence‐to‐dose conversion factors. The values of absorbed dose obtained from the unfolding of experimental data agree with the values obtained from the calculated spectra within the estimated uncertainty of ±25%. These values are ∼5×10 −3 rad on the beam axis and ∼1×10 −3 rad at distances greater than 20 cm, perpendicular to the beam axis, per rad deposited by the incident alpha‐particle beam in the plateau. Estimates of upper limits of dose to two critical organs, the lens of the eye and red bone narrow, are ∼25 rad and ∼5 rad, respectively, for a typical treatment plan.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here